glp-1 agonists marketing strategies 2025 Market Size, Share, Growth Insights 2032 Glucagon Like Peptide-1 (GLP-1) Agonists

18000 Rs

Platelet-Rich Plasma (PRP): A regenerative therapy using the patients own platelets to stimulate healing and reduce chronic tendon inflammation

Several studies have identified a significant association between elevated hs-TnT at admission and at discharge with adverse events in patients hospitalised with decompensated HFpEF.4042 The predictive capabilities of hs-cTnT and hs-cTnI for secondary events in HFpEF have also been assessed

Liraglutide (LIRA) and semaglutide (SEMA) gained approval by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for weight reduction in obese individuals or people who are overweight with BMI 27 kg/m 2 and also experience at least one weight-associated comorbid situation (such as hypertension, dyslipidemia, prediabetes and OSA) combined to lifestyle modifications [71]